| |
Triala
|
Baseline
|
post-M1
|
post-M2
|
pre-M2
|
post-M3
|
|---|
|
Urea (mM)1
|
AA
|
4.61 ± 1.72
|
8.20 ± 3.65
|
12.70 ± 4.50*
|
13.25 ± 4.10*
|
17.56 ± 5.30*
|
|
PL
|
4.55 ± 1.90
|
7.36 ± 2.30
|
12.95 ± 5.00*
|
9.07 ± 4.00
|
16.92 ± 5.10*
|
|
Lactate (mM)2
|
AA
|
2.95 ± 0.77
|
13.38 ± 4.17*
|
12.78 ± 3.77
|
2.22 ± 0.53
|
11.93 ± 2.90
|
|
PL
|
3.19 ± 0.75
|
13.37 ± 2.96*
|
12.24 ± 3.45
|
2.36 ± 0.55
|
12.57 ± 2.27
|
|
Glucose (mM)3
|
AA
|
5.26 ± 0.28
|
4.39 ± 0.44*
|
4.97 ± 0.50
|
5.37 ± 0.39
|
5.12 ± 0.50
|
|
PL
|
5.25 ± 0.44
|
4.20 ± 0.27*
|
4.89 ± 0.39
|
5.36 ± 0.22
|
5.28 ± 0.39
|
|
Glycerol (μM)4
|
AA
|
27.75 ± 10.37
|
49.38 ± 22.00
|
76.48 ± 27.14*
|
79.81 ± 24.91*
|
105.78 ± 31.76*
|
|
PL
|
27.42 ± 11.39
|
44.34 ± 13.96
|
78.00 ± 30.22*
|
54.65 ± 24.31
|
101.91 ± 30.93*
|
|
NEFA (mM)b,5
|
AA
|
0.33 ± 0.17
|
0.21 ± 0.08
|
0.34 ± 0.15
|
0.38 ± 0.12
|
0.47 ± 0.20
|
|
PL
|
0.36 ± 0.16
|
0.21 ± 0.06
|
0.38 ± 0.10
|
0.58 ± 0.24
|
0.55 ± 0.19
|
|
RPEc,6
|
AA
|
9.3 ± 2.0
|
16.0 ± 2.0*
|
15.9 ± 2.0*
|
-
|
15.2 ± 3.0*
|
|
PL
|
9.3 ± 2.0
|
12.8 ± 2.0*
|
13.6 ± 2.0*
|
-
|
14.6 ± 2.0*
|
-
a
AA BCAA, arginine, and citruline, PL placebo. b
NEFA non-esterified fatty acid. c
RPE ratings of perceived exertion. *Significantly different from baseline in the same trial (p < .05)
-
1Main effects: trial: p = .329; time: p < .001; interaction: p = .167
-
2Main effects: trial: p = .325; time: p < .001; interaction: p = .165
-
3Main effects: trial: p = .816; time: p < .001; interaction: p = .520
-
4Main effects: trial: p = .325; time: p < .001; interaction: p = .165
-
5Main effects: trial: p = .117; time: p < .001; interaction: p = .213
-
6Main effects: trial: p = .886; time: p = .003; interaction: p = .718
